UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2020-06, Vol.31 (6), p.697-712

2020

Volltextzugriff (PDF)

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

Journal of hematology and oncology, 2017-01, Vol.10 (1), p.24-24, Article 24

2017

Volltextzugriff (PDF)

Development of a standardized MRI protocol for pancreas assessment in humans

PloS one, 2021-08, Vol.16 (8), p.e0256029-e0256029

2021

Volltextzugriff (PDF)

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

Bone marrow transplantation (Basingstoke), 2014-02, Vol.49 (2), p.280-286

2014

Volltextzugriff (PDF)

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

Leukemia, 2013-05, Vol.27 (5), p.1028-1036

2013

Volltextzugriff (PDF)

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.825-832

2016

Volltextzugriff (PDF)

Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML

Bone marrow transplantation (Basingstoke), 2008-03, Vol.41 (5), p.415-423

CRADDOCK, C. F

2008

Volltextzugriff (PDF)

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2014-03, Vol.49 (3), p.389-396

2014

Volltextzugriff (PDF)

Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival

Bone marrow transplantation (Basingstoke), 2013-02, Vol.48 (2), p.243-248

2013

Volltextzugriff (PDF)

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

Leukemia, 2015-12, Vol.29 (12), p.2375-2381

2015

Volltextzugriff (PDF)

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Leukemia, 2011-05, Vol.25 (5), p.808-813

2011

Volltextzugriff (PDF)

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

Leukemia, 2005-10, Vol.19 (10), p.1751-1759

2005

Volltextzugriff (PDF)

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

Journal of internal medicine, 2018-04, Vol.283 (4), p.371-379

2018

Volltextzugriff (PDF)

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

Bone marrow transplantation (Basingstoke), 2024-02, Vol.59 (2), p.232-238

2024

Volltextzugriff (PDF)

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

Bone marrow transplantation (Basingstoke), 2016-03, Vol.51 (3), p.418-423

2016

Volltextzugriff (PDF)

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.783-789

2008

Volltextzugriff (PDF)

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia

Leukemia, 2015-07, Vol.29 (7), p.1478-1484

2015

Volltextzugriff (PDF)

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2015-08, Vol.50 (8), p.1063-1068

2015

Volltextzugriff (PDF)

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

Bone marrow transplantation (Basingstoke), 2010-11, Vol.45 (11), p.1587-1593

2010

Volltextzugriff (PDF)

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

Bone marrow transplantation (Basingstoke), 2014-05, Vol.49 (5), p.671-678

2014

Volltextzugriff (PDF)

Guidelines on the management of acute myeloid leukaemia in adults

British journal of haematology, 2006-11, Vol.135 (4), p.450-474

2006

Volltextzugriff (PDF)

Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.286-287

2016

Volltextzugriff (PDF)

Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation

Bone marrow transplantation (Basingstoke), 2012-04, Vol.47 (4), p.528-534

2012

Volltextzugriff (PDF)

Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience

Transfusion medicine (Oxford, England), 2015-12, Vol.25 (6), p.418-423

2015

Volltextzugriff (PDF)

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (11), p.853-861

2009

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(210)
Mit Volltextzugriff
(183)

Publikationsform

Artikel
(213)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

Development of a standardized MRI protocol for pancreas assessment in humans

EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT

Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML

Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

Cryopreservation of allogeneic PBSC from related and unrelated donors is associated with delayed platelet engraftment but has no impact on survival

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

Distinct factors determine the kinetics of disease relapse in adults transplanted for acute myeloid leukaemia

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant

A comparative assessment of the curative potential of reduced intensity allografts in acute myeloid leukaemia

Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT

The role of allogeneic SCT in primary myelofibrosis: a British Society for Blood and Marrow Transplantation study

Matched unrelated donor allogeneic transplantation provides comparable long-term outcome to HLA-identical sibling transplantation in relapsed diffuse large B-cell lymphoma

Guidelines on the management of acute myeloid leukaemia in adults

Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening

Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation

Transfusion in CMV seronegative T‐depleted allogeneic stem cell transplant recipients with CMV‐unselected blood components results in zero CMV transmissions in the era of universal leukocyte reduction: a UK dual centre experience

Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT

Aktive Filter

Suchergebnisse filtern